Studies Confirming Efficacy Of Pillcam Sb For Detecting Small Bowel Diseases Presented At Ueg Week

New Clinical Study Shows Over Half of Eligible OGIB Patients May Benefit From Small Bowel Capsule Endoscopy as

"Emergency Video Capsule Endoscopy in Patients with Acute Gastrointestinal Bleeding, poster," poster P1332:presented by Christoph Schlag M.D., and colleagues, Technical University Munich, Munich, Germany, analyzed the use of PillCam capsule endoscopy (CE) for acute gastrointestinal bleeding in the emergency setting. Of the patients who failed to have their source of bleeding identified with gastroscopy, 93% showed complete examination using emergency CE and 73% had the bleeding source identified with CE. Results confirm that for patients with signs of acute upper/mid gastrointestinal bleeding who have had a negative gastroscopy, emergency CE can be used to immediately detect the bleeding source and to guide therapy. About UEG Week UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning. About PillCam SB The PillCam SB capsule is a minimally invasive procedure to visualize and monitor small bowel abnormalities associated with Crohn's disease, iron deficiency anemia (IDA) and obscure GI bleeding (OGIB). The PillCam measures 11 mm x 26 mm and weighs less than four grams. Now in its third generation, PillCam SB 3 contains an imaging device and light source and transmits images at a rate between two and six images per second. Initially cleared by the U.S. Food and Drug Administration in 2001, PillCam SB is an accurate, patient-friendly tool used in patients two years and older by physicians to visualize the small bowel. PillCam SB 3 builds on Given Imaging's unique expertise and collaborative efforts as an industry leader that includes more than 2 million uses of PillCam capsules in patients worldwide and more than 1,900 clinical studies. The risks of PillCam capsule endoscopy include capsule retention, aspiration and skin irritation. Endoscopic placement may present additional risks. Medical, endoscopic, or surgical intervention may be necessary to address any of these complications, should they occur. understanding

The grading systems used in the study were developed to assist clinicians and policymakers in determining when sufficient evidence has accumulated to incorporate new technologies into clinical practice. New, Simplified Procedure for PillCam(R) of the Small Bowel In separate news, the company also demonstrated a simplified procedure for performing PillCam capsule endoscopy of the small bowel. First unveiled to nurses at the Society of Gastroenterology Nurses and Associates (SGNA) meeting which took place in St. Louis, from May 15 - 20, the simplified procedure that uses the new SensorBelt with the RecorderPouch and obviates the need to use the sensor array and recorder belt previously required. The new procedure has been very well received, with nurses surveyed indicating that this new procedure would save them time and be welcomed by their patients. Specifically, the nurses also indicated that, on average, they would save 15 to 30 minutes of preparation and maintenance time per procedure. Both products can be washed or disinfected using common liquid disinfectants and are priced to enable cost-effective reorder. The RecorderPouch is available now while the SensorBelt is pending 510(k) clearance. "This new procedure makes a patient-friendly diagnostic test even easier while improving workflow productivity at the same time," said Pat Moushey, RN, CGRN, St. Luke's Hospital, St. Louis. "The SensorBelt reduces the time required to prepare the patient for a capsule endoscopy and time spent on equipment preparation and maintenance. The RecorderPouch is less visible and allows greater freedom of movement for patients." Next-Generation Software The latest version of RAPID(R) Software Suite, which includes RAPID 6, RAPID(R) 6 Access and RAPID(R) 6 Reader, incorporates the following new features: -- Image Adjustment with FICE (Flexible spectral Imaging Color Enhancement), developed by FUJIFILM, a partner of Given Imaging. FICE is an image-enhancing technology that aids the physician in viewing surface tissue characteristics and blood vessels by visually enhancing potential areas of disease; -- PillCam Progress Indicator, which may aid in planning therapeutic intervention by providing an estimation of linear distance within the small bowel along with information concerning rate of capsule progress through the small bowel; -- Mosaic View, which allows the reader to view an array of consecutive images showing how the tissue changes as the PillCam video capsule progressed; -- An updated Study Manager and patient management screens including user- customizable fields, pull-down menus for easy, error-free data entry and an exportable database. About Occult GI Bleeding Occult gastrointestinal bleeding (OGIB) occurs when blood is lost from the digestive tract without visible, or overt, signs of bleeding.(2) The condition is usually discovered only with positive results for a fecal occult blood test or through detection of iron deficiency anemia, and there are many potential causes. learn here

Given Imaging Announces New Studies Showing PillCam SB Can Detect and Monitor Small Bowel Crohn's Disease

Emergency intervention was required in just four cases, three of which were managed endoscopically and one of which was managed surgically. Non-emergency cases were managed endoscopically in eight cases and surgically in 7 cases. Three capsules dislodged after steroid treatment and three cases resolved without intervention. About Crohn's Disease Crohn's disease is a chronic condition that causes inflammation in the lining of the small intestine wall and can affect any part of the digestive tract. Symptoms can include diarrhea, abdominal pain, weight loss and rectal bleeding. Roughly 50 percent of all cases of Crohn's disease are diagnosed in the last part of the small intestine (the terminal ileum) and cecum. This area is also known as the ileocecal region. Other cases of Crohn's may affect one or more of the following: the colon only, the small bowel only (duodenum, jejunum and/or ileum), the stomach or esophagus.(1) Roughly 500,000 Americans suffer from Crohn's disease, and about 20 percent have a direct relative with some form of inflammatory bowel disease (IBD).(2) It affects men and women equally. The cause is unknown, but the most popular theory is that the immune system is reacting to a virus or bacterium that causes inflammation.(3) Depending on the severity, treatment options include nutritional supplements, drugs and surgery. There is currently no cure for the disease.(4) About PillCam SB The PillCam SB video capsule measures 11 mm x 26 mm and weighs less than four grams. Now in its second generation, PillCam SB 2 contains an imaging device and light source and transmits images at a rate of two images per second generating more than 50,000 pictures during the course of the procedure. Initially cleared by the U.S. Food and Drug Administration in 2001, PillCam SB is clinically validated by more than 1,500 peer-reviewed studies. recommended site